Glycine receptor antibodies: Clinical spectrum and pathogenic mechanisms of the antibodies

Glycine receptor antibodies: Clinical spectrum and pathogenic mechanisms of the antibodies

Bibliographic Details
Main Authors:	Carvajal, A, Leite, M, Clover, L, Woodhall, M, Waters, P, Vincent, A
Format:	Conference item
Published:	2012

Similar Items

Glycine receptor antibodies: pathogenic mechanisms and clinical corrlates
by: Carvajal González, A
Published: (2014)

EXPANDING THE PHENOTYPIC SPECTRUM OF PROGRESSIVE ENCEPHALOMYELITIS WITH RIGIDITY AND MYOCLONUS SYNDROME (PERMS) ASSOCIATED WITH GLYCINE RECEPTOR ANTIBODY: CLINICAL AND LABORATORY STUDY OF 20 PATIENTS
by: Leite, M, et al.
Published: (2012)

Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes.
by: Carvajal-González, A, et al.
Published: (2014)

IMMUNOTHERAPY-RESPONSIVE STATUS EPILEPTICUS WITH ANTI-GLYCINE RECEPTOR ANTIBODY
by: Zuliani, L, et al.
Published: (2011)

PATHOLOGICAL MECHANISMS OF GLYCINE RECEPTOR ANTIBODIES
by: Crisp, S, et al.
Published: (2014)

Progressive encephalomyelitis with rigidity and myoclonus: the first pediatric case with glycine receptor antibodies.
by: Damásio, J, et al.
Published: (2013)

PROGRESSIVE ENCEPHALOMYELITIS WITH RIGIDITY AND MYOCLONUS: THE FIRST PAEDIATRIC CASE WITH GLYCINE RECEPTOR ANTIBODIES
by: Damasio, J, et al.
Published: (2011)

Pathological mechanisms in patients with antibodies to glycine receptors
by: Crisp, S, et al.
Published: (2014)

Teratoma-derived glycine receptor antibodies in progressive encephalomyelitis with rigidity and myoclonus
by: Sun, B, et al.
Published: (2019)

Glycine receptor antibody — a marker for NMO/ NON-MS demyelination?
by: Hamid, S, et al.
Published: (2015)

Glycine receptor antibodies in 2 cases of new, adult-onset epilepsy.
by: Zuliani, L, et al.
Published: (2014)

Progressive encephalomyelitis with rigidity and myoclonus: glycine and NMDA receptor antibodies.
by: Turner, M, et al.
Published: (2011)

Glycine receptor antibodies in a boy with focal epilepsy and episodic behavioral disorder
by: Wuerfel, E, et al.
Published: (2014)

Glycine receptor antibodies in a boy with focal epilepsy and episodic behavioral disorder.
by: Wuerfel, E, et al.
Published: (2014)

Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica.
by: Woodhall, M, et al.
Published: (2013)

Supranuclear gaze palsy in glycine receptor antibody-positive progressive encephalomyelitis with rigidity and myoclonus
by: Peeters, E, et al.
Published: (2012)

Supranuclear gaze palsy in glycine receptor antibody-positive progressive encephalomyelitis with rigidity and myoclonus.
by: Peeters, E, et al.
Published: (2012)

Glycine receptor antibodies are detected in progressive encephalomyelitis with rigidity and myoclonus (PERM) but not in saccadic oscillations.
by: Iizuka, T, et al.
Published: (2012)

Glycine receptor antibodies are detected in progressive encephalomyelitis with rigidity and myoclonus (PERM) but not in saccadic oscillations
by: Iizuka, T, et al.
Published: (2011)

PATHOGENIC MECHANISMS UNDERLYING MYASTHENIA GRAVIS ASSOCIATED WITH MUSK ANTIBODIES
by: Viegas, S, et al.
Published: (2009)

A case of glycine-receptor antibody-associated encephalomyelitis with rigidity and myoclonus (PERM): clinical course, treatment and CSF findings.
by: Piotrowicz, A, et al.
Published: (2011)

Pathogenic potential of antibodies to the GABA B receptor
by: Nibber, A, et al.
Published: (2017)

Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody.
by: Hutchinson, M, et al.
Published: (2008)

Antibodies to AMPA receptors in Rasmussen's encephalitis.
by: Nibber, A, et al.
Published: (2016)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
by: Kitley, J, et al.
Published: (2013)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
by: Kitley, J, et al.
Published: (2013)

Antibodies to clustered acetylcholine receptor and thymic changes in seronegative myasthenia gravis
by: Leite, M, et al.
Published: (2007)

Aquaporin-4 Antibody Isoform Binding Specificity Does Not Explain Clinical Variations in Neuromyelitis Optica
by: Kitley, J, et al.
Published: (2013)

Hypoventilation in glycine-receptor antibody related progressive encephalomyelitis, rigidity and myoclonus.
by: Bourke, D, et al.
Published: (2014)

Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study
by: Kitley, J, et al.
Published: (2014)

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
by: Kitley, J, et al.
Published: (2014)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
by: Waters, P, et al.
Published: (2016)

IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis.
by: Leite, M, et al.
Published: (2008)

Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS
by: Waters, P, et al.
Published: (2015)

NEUROMYELITIS OPTICA SPECTRUM AND RELATIONSHIP WITH AQUAPORIN-4 ANTIBODY DISEASE: THE OXFORD COHORT
by: Leite, M, et al.
Published: (2009)

Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis.
by: Jacob, S, et al.
Published: (2012)

Recurrent optic neuritis associated with MOG antibody seropositivity
by: Chang, T, et al.
Published: (2017)

RELAPSING AQP4 ANTIBODY NEGATIVE NMO WITH MOG ANTIBODIES
by: Elsone, L, et al.
Published: (2014)

Classifying the antibody-negative NMO syndromes: Clinical, imaging, and metabolomic modeling
by: Yeo, T, et al.
Published: (2019)

A novel fluorescent immunoprecipitation (FIPA) method to detect antibodies to new targets in antibody-mediated diseases
by: Waters, P, et al.
Published: (2008)